Skip to main content
Equibles

Jens Schroeder Kemp

Analyst

Team Member

Axogen, Inc. (AXGN)

Equibles does not estimate personal net worth.

About Jens Schroeder Kemp

Jens Schroeder Kemp is recorded as Analyst at Team Member. Jens Schroeder Kemp has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for Axogen, Inc. on September 10, 2026. Axogen, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Axogen, Inc. includes Michael Dale (CEO and Board Member), Paul G. Thomas (Chairman and Board Member), Paul Thomas (Chairman) and 7 others.

Jens Schroeder Kemp on recent calls

“Yeah, so as Mike alluded to, nerve tape really is what we consider kind of a next generation connection device. So in cases where the Axigar connector is used as a direct co-opulation mechanism, nerve tape could be another option that the surgeons use.”
Axogen Acquires BioCircuit Technologies Conference Call ·
“Yeah, I think when you look at the breast growth, we see both existing programs accelerating adoption, and within those programs, that's driven by existing surgeons, but we're also successfully activating new surgeons within these existing programs.”
Second Quarter 2026 Financial Results Conference Call ·
“Yeah, I mean, we're looking at, basically, we're following these patients very closely, or the sites that we're working with are following patients very closely, and we're looking for clinical signs for potency and continence.”
Axogen, Inc. Q1 FY2026 Earnings Call ·
“As we increase our target indications and target procedures, that high-potential algorithm will evolve. And so we do expect in the future that that universe of high-potential accounts will grow.”
Axogen, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Leadership on record at Axogen, Inc.

Recent activity